Megamonas funiformis
Selected indexed studies
- Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid. (NPJ Biofilms Microbiomes, 2023) [PMID:37925493]
- Megamonas funiformis, Plasma Zonulin, and Sodium Intake Affect C3 Complement Levels in Inactive Systemic Lupus Erythematosus. (Nutrients, 2023) [PMID:37111218]
- Complete Genome Sequence of Megamonas funiformis Strain 1CBH44, Isolated from Human Feces. (Microbiol Resour Announc, 2021) [PMID:34854722]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid. (2023) pubmed
- Megamonas funiformis, Plasma Zonulin, and Sodium Intake Affect C3 Complement Levels in Inactive Systemic Lupus Erythematosus. (2023) pubmed
- Complete Genome Sequence of Megamonas funiformis Strain 1CBH44, Isolated from Human Feces. (2021) pubmed
- Author Correction: Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid. (2024) pubmed
- Complete Genome Sequence of Megamonas funiformis JCM 14723(T). (2020) pubmed
- Panose prevents acute-on-chronic liver failure by reducing bacterial infection in mice. (2025) pubmed
- Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles. (2024) pubmed
- Draft Genome Sequence of Megamonas funiformis Strain Marseille-P3344, Isolated from a Human Fecal Microbiota. (2018) pubmed
- Fecal microbiota transplantation against moderate-to-severe atopic dermatitis: A randomized, double-blind controlled explorer trial. (2025) pubmed
- Exploring potential therapeutic targets for myopia: Causal analysis and biological annotation with gut microbiota. (2026) pubmed